相关实验视频
Updated: Jan 9, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
作为抗癌剂的类固醇支架:进化,FDA批准,合成衍生物,SAR概况和翻译视角
Prabhugouda Gugal1, Hemalatha Kamurthy1, Rohit Pal1
1Integrated Drug Discovery Center, Acharya & B M Reddy College of Pharmacy, Bengaluru, Karnataka, India.
类固醇衍生物在抗癌药物开发中至关重要,它们对各种癌症具有强烈的活性. 新型合成策略和组合正在提高它们在耐药和转移性癌症的精密医学中的潜力.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 药物开发 药物开发
背景情况:
- 类固醇支架对于抗癌药物开发至关重要,因为它们的结构和生物特性.
- 葡萄糖皮质类药物和激素调节剂是针对血液学和激素依赖性癌症的既定治疗方法.
- 类固醇具有刚性结构,良好的膜透性和受体亲和力.
研究的目的:
- 探索类固醇衍生物在抗癌治疗中的开发,合成创新和临床潜力.
- 为了突出基于类固醇的药物设计在精准医学时代的复兴.
- 审查类固醇抗癌剂的治疗前景和未来方向.
主要方法:
- 关于类固醇抗癌剂的现有文献的全面审查.
- 对FDA批准的类固醇药物和新型合成混合物的分析.
- 评估新型类固醇衍生物的体外细胞毒性潜力 (IC50值).
主要成果:
- 新型类固醇衍生物具有强烈的抗癌活性,具有较低的IC50值 (例如,0.00083μM的化合物32).
- 在固体瘤模型中,结合异环的合成杂交体显示出增强的效能和选择性.
- 研究性类固醇药物组合正在进行高级癌症的临床试验.
结论:
- 类固醇衍生物是针对性和支持性癌症治疗的基石.
- 新兴的合成策略正在提高类固醇对抗性和转移性癌症的转化活力.
- 基于类固醇的药物设计在精准医学时代对于开发新型抗癌剂至关重要.
更多相关视频
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
相关概念视频
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Drug Products: Biologics, Biosimilars and Interchangeables
Mitogens and the Cell Cycle